These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22158266)

  • 1. Co-occurring weight problems among children with attention deficit/hyperactivity disorder: the role of executive functioning.
    Graziano PA; Bagner DM; Waxmonsky JG; Reid A; McNamara JP; Geffken GR
    Int J Obes (Lond); 2012 Apr; 36(4):567-72. PubMed ID: 22158266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
    Findling RL; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; DeLeon A; Ginsberg LD
    J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):28-35. PubMed ID: 23410139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
    Turgay A; Ginsberg L; Sarkis E; Jain R; Adeyi B; Gao J; Dirks B; Babcock T; Scheckner B; Richards C; Lasser R; Findling RL
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):503-11. PubMed ID: 21186969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
    Byrd HC; Curtin C; Anderson SE
    Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of medication by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
    Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder.
    Waxmonsky JG; Pelham WE; Baweja R; Hale D; Pelham WE
    J Pediatr; 2022 Feb; 241():115-125.e2. PubMed ID: 34571023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between binge eating and attention-deficit/hyperactivity disorder in two pediatric community mental health clinics.
    Reinblatt SP; Leoutsakos JM; Mahone EM; Forrester S; Wilcox HC; Riddle MA
    Int J Eat Disord; 2015 Jul; 48(5):505-11. PubMed ID: 25130278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between chronotype and obesity in children and adolescent with attention deficit hyperactivity disorder.
    Türkoğlu S; Çetin FH
    Chronobiol Int; 2019 Aug; 36(8):1138-1147. PubMed ID: 31177853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants.
    Yackobovitch-Gavan M; Mimouni-Bloch A; Gabbay U; Carmi D; Goldstein B; Keinan-Boker L; Bloch S; Meyerovitch J
    J Pediatr; 2021 Nov; 238():296-304.e4. PubMed ID: 34293373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the relationship between attention-deficit/hyperactivity disorder and overweight in children and adolescents.
    Erhart M; Herpertz-Dahlmann B; Wille N; Sawitzky-Rose B; Hölling H; Ravens-Sieberer U
    Eur Child Adolesc Psychiatry; 2012 Jan; 21(1):39-49. PubMed ID: 22120761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive Function and Attention Performance in Children with ADHD: Effects of Medication and Comparison with Typically Developing Children.
    Miklós M; Futó J; Komáromy D; Balázs J
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31658722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.
    Vance AL; Maruff P; Barnett R
    Aust N Z J Psychiatry; 2003 Oct; 37(5):570-6. PubMed ID: 14511085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
    van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.